Related Experiment Video
Updated: Apr 16, 2026
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
Nomogram for Predicting Pancreatic Pseudocyst in Hypertriglyceridemic Acute Pancreatitis: A Retrospective Cohort
Rui Qi1, Jinzhi Zhong1, Hebin Wang1
1Department of Hepatobiliary Surgery, Affiliated Hospital of Panzhihua University, Panzhihua Hospital of Integrated Traditional Chinese and Western Medicine, Panzhihua, Sichuan, People's Republic of China.
Purpose:
Pancreatic pseudocyst (PPC) is a relatively common local complication of hypertriglyceridemic acute pancreatitis (HTG-AP), frequently associated with prolonged hospital stay and potentially increased need for minimally invasive intervention. However, there is currently no established PPC prediction tool based on early admission indicators for HTG-AP patients.
Patients And Methods:
In this retrospective study, 684 HTG-AP patients from January 2017 to January 2025 were included. All the patients were divided into training and validation sets in a 7:3 ratio. The least absolute shrinkage and selection operator regression was utilized for preliminary screening of predictive factors in the training set. Then, multivariate logistic regression was applied to identify potential factors for nomogram construction.
Results:
A total of 684 patients were included, with an overall PPC incidence of 15.7%. The model incorporated three predictors: systemic inflammatory response syndrome (SIRS) (odds ratio [OR] = 2.263, 95% confidence interval [CI]: 1.283-3.991, p = 0.005), C-reactive protein (CRP) (OR = 1.019, 95% CI: 1.013-1.026, p < 0.001), and lactate (OR = 3.219, 95% CI: 2.182-4.749, p < 0.001). The nomogram showed good discrimination, with an area under the curve (AUC) of 0.816 (95% CI: 0.759-0.869) in the training cohort and 0.760 (95% CI: 0.658-0.854) in the validation cohort. Calibration performance was acceptable, with calibration slopes of 1.000 and 0.773 and Brier scores of 0.100 and 0.108 in the training and validation cohorts, respectively. Decision curve analysis further demonstrated positive net clinical benefit in both cohorts.
Conclusion:
SIRS, CRP, and lactate may be associated with the occurrence of PPC in patients with HTG-AP and may have value for early risk assessment. We developed a nomogram for PPC risk stratification in this population; however, further external validation is needed to confirm its generalizability and potential clinical utility.
Related Concept Videos
01:30Acute Pancreatitis II: Clinical Manifestations and Management
01:27Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
01:29Chronic Pancreatitis II: Collaborative Care
Assessment: